basis of spectrin deficiency is unknown. Here we report two mechanisms underlying spectrin deficiency in HPP. The first mechanism involves a thalassemia-like defect characterized by a reduced synthesis of a-spectrin as shown by studies involving synthesis of spectrin in two unrelated HPP probands and their parents: One parent carries the elliptocytogenic spectrin mutation, whereas the other parent is fully asymptomatic. Peripheral blood mononuclear cells as a source of erythroid burst-forming unit (BFUe) were cultured in a two-phase liquid culture system that gives rise to terminally differentiated erythroblasts. Pulse-labeling studies of an equal number of erythroblasts of morphologically identical maturity showed that the synthesis of a-spectrin as well as the mRNA levels as measured by the competitive polymerase chain reaction (PCR) EREDITARY pyropoikilocytosis (HPP) is a relatively H rare, severe recessively inherited hemolytic anemia characterized by striking micropoikilocytosis and microspherocytosis and a thermal instability of the red blood cells (RBCs).' Typically, subjects with HPP have two biochemical abnormalities: ( I ) they are partially deficient in spectrin, and (2) they carry mutant a-spectrin or /I-spectrin causing a defect involving spectrin self-ass~ciation,~~~ which results in an increased amount of spectrin dimers as opposed to tetramers in the 0°C crude spectrin e~t r a c t .~ Although many mutations causing defective spectrin self-association have now been defined,'-* the molecular basis of spectrin deficiency in HPP is unknown. At least two subsets of patients with HPP can be identified, which suggests heterogeneous 0 1993 by The American Society of Hematology. 0006-4971 /93/8205-0031$3.00/0 method are markedly reduced in the presumed asymptomatic carriers and the HPP probands. In contrast, the synthesis and mRNA levels of j3-spectrin were normal. These results constitute a direct demonstration of an a-spectrin synthetic defect in a subset of asymptomatic carriers of HPP and HPP probands. The second mechanism underlying spectrin deficiency involves increased degradation of mutant spectrin before its assembly on the membrane. This is evidenced by pulse labeling studies of erythroblasts from a patient with HPP associated with a homozygous state for spectrin a'/* mutation (leu-pro mutation at AA 207 of a-spectrin). These studies showed that although spectrin is synthesized in the cytosol in normal amounts, the rate of turnover of a-spectrin is faster resulting in about 40% to 50% reduced assembly of a-spectrin and 8-spectrin on the membrane. Thus, spectrin deficiency in this case is at least in part caused by increased susceptibility of the mutant spectrin to degradation before its assembly on the membrane. We conclude that at least two separate mechanisms underlie the molecular basis of spectrin deficiency in HPP. 0 7993 by The American Society of Hematology. molecular mechanisms. The first group includes those patients with HPP who are presumed double heterozygotes for two defects: (1) a spectrin mutation and (2) a putative defect involving reduced synthesis of a-spectrin. This possibility is suggested by a characteristic pattern of HPP inheritance: Typically, one of the parents of the HPP offspring carries an a-spectrin or P-spectrin mutation and has either mild hereditary elliptocylosis (HE) or is an asymptomatic carrier of such defect; The other parent is hematologically normal and has no detectable abnormalities in membrane protein composition and function. Because the RBCs of the HPP offspring have considerably greater amounts of the mutant spectrin than those of the affected parent and exhibit a partial spectrin deficiency, we hypothesized that the asymptomatic parent transmits to the HPP offspring a genetic defect involving reduced synthesis of a-spectrin, which increases the quantitative expression of the mutant spectrin and causes a concomitant partial spectrin deficiency.
In normal RBCs, a-spectrin is synthesized in twofold to threefold excess over P-spectrin; however, on the membrane, the two polypeptides are assembled stoichiometrically and their amount depends on the number of copies of membrane-associated ankyrin.'-'' The unassembled aspectrin and b-spectrin polypeptides are rapidly degraded in the cytosol. Because of this uneven a-spectrin and @-spectrin synthesis with large excess of the synthesis of a-spectrin over b-spectrin, a carrier of a synthetic defect of a-spectrin is likely to be fully asymptomatic, because the actual synthesis of a-spectrin may still exceed that of b-spectrin.
The second group of patients with HPP involves patients who are either homozygous for the elliptocytogenic mutation of spectrin or they are doubly heterozygous for two spectrin mutations. We examined a possibility that in such patients, spectrin deficiency involves an instability of the mutant spectrin leading to a premature degradation of this protein before its assembly on the membrane.
To determine the molecular basis of spectrin deficiency in these two subsets of patients with HPP, we have studied the synthesis, assembly, and turnover of a-spectrin and 8spectrin in HPP and control erythroblasts isolated from two-phase liquid cultures of peripheral blood (PB) mononuclear cells. We provide evidence that the spectrin deficiency in HPP is a consequence of at least two distinct mechanisms proposed above. The first underlying mechanism involves reduced synthesis and mRNA content of a spectrin in two unrelated presumed asymptomatic carriers and HPP probands. The second mechanism underlying spectrin deficiency in HPP patients who are either homozygous or doubly heterozygous for one or two spectrin mutations, respectively, involves increased degradation of the mutant spectrin before its assembly on the membrane.
MATERIALS AND METHODS

Subjects.
The first subject, S.B., is a 37-year-old white woman with severe HPP requiring splenectomy. Her blood smear showed marked poikilocytes, microspherocytes, and RBC fragmentation. Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting analysis showed the presence of truncated a-spectrin in the RBC membranes with an approximate molecular weight of 235 Kd that migrated just below the intact a-spectrin chain on SDS gels. Furthermore, the spectrin to band 3 ratio was markedly decreased from I .O to 0.68 indicating a moderately severe deficiency of spectrin. The amount of the truncated a-spectrin was approximately 10% of intact a-spectrin chain.
There was an increased proportion of spectrin dimers (29% as compared with 4% in controls) in the crude 4°C spectrin extract as well as an increased amount of fragment and a decreased amount of the normal 80-Kd fragment after two-dimensional gel analysis of a partial tryptic digest of spectrin. The underlying molecular defect involves an insertion within the a-spectrin gene leading to an inframe deletion ofexon 5 at the cDNA level." The mother of subject S.B., V.B., canies the spectrin mutant, whereas the father, C.B., is hematologically and biochemically normal (with normal amounts of spectrin, 80-Kd fragment, and spectrin dimers in the crude 4°C spectrin extract).
The second subject, B.S., is a 13-year-old white girl with severe HPP requiring splenectomy at the age of4. The PB film showed the presence of microspherocytes, poikilocytes, and RBC fragments. Biochemical analysis showed an increased proportion of spectrin dimers in the crude 4°C extract (37% as compared with 5% in controls). The spectrin to band 3 ratio was 0.76 as compared with control values of 1.0, indicating a partial deficiency of spectrin. Structural studies indicated that the subject is heterozygous for spectrin mutation with an increased amount of the fragment and a markedly decreased amount of the normal 80-Kd fragment in the limited tryptic digest of spectrin. Her father, P.S., carries the spectrin mutant, whereas the mother, K.S., is hematologically and biochemically normal. The underlying defect in subjects carrying the spectrin mutant involves a point mutation causing arginine to histidine (CGT-CAT) substitution at codon 28 of a-spectrin.
The clinical and biochemical data on the third patient, T.N., HPP who is a homozygote for spectrin mutation, has been reported previously by Coetzer et The subject is a 2 1-year-old black man with severe inherited hemolytic anemia fulfilling the diagnostic criteria of HPP. The underlying defect has recently been identified as a point mutation causing the replacement of leucine by proline at amino acid 207 in the a-spectrin chain.I4 His mother is an asymptomatic spectrin carrier and his father is not available for studies. Venous blood was collected from the subjects and normal control donors in tubes or bags containing acid citrate dextrose as anticoagulant. The samples were cooled and transported overnight on ice in insulated containers to Boston, where they were analyzed immediately.
Two-phase liquid culture system for the maturation of erythroid progenitors. PB was obtained from healthy donors and patients, and mononuclear cells were separated by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) gradient density centrifugation. The mononuclear cells were collected and cultured using a slight modification of the two-phase liquid culture system described by Fibach et all' and Wada et al.I6 The mononuclear cells were cultured in the first phase at a density of 106/mL in alpha minimum essential medium (MEM) (GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS) (Hyclone, Logan, UT) and 10% conditioned medium collected from cultures of the 5637 bladder carcinoma cell line.17 After a 1-week incubation at 37°C in an atmosphere of 5% C 0 2 , the nonadherent cells were harvested and treated by the carbonyl iron method" to remove phagocytic cells. The floating, nonphagocytic cells were recultured in alpha medium containing 30% FCS, 1% deionized bovine serum albumin (BSA), lo-' mol/L 2-mercaptoethanol, 1.5 mmol/L glutamine, mol/ L dexamethasone, cyclosporine A, and 1 U/mL human recombinant erythropoietin (generously provided by Ortho Biotec, Raritan, NJ). These secondary cultures were incubated at 37°C in a humidified atmosphere containing 5% O2 and 5% C02. After 4 days in the second phase, when clusters of proerythroblasts start to appear, the cells were harvested (the medium was saved), suspended in 2 mL of the culture medium, layered on a 2-mL solution of 45% Percoll (Pharmacia) in phosphate-buffered saline (PBS) (final density = 1.0585 g/mL), and centrihged at 2000 rpm for 5 minutes at room temperature. The upper layer containing predominantly proerythroblasts were collected, washed, resuspended in the original culture medium, and incubation continued at 37°C in an atmosphere of 5% O2 and 5% C02. The pellet containing greater than 90% of the lymphocytes was discarded. After 1 week in the second phase, viable cells were counted by trypan blue exclusion. Hemoglobin-containing cells were scored with use ofthe acetic acid-benzidine peroxide reaction" and cellular morphology assessed by preparing cytospin slides stained with Wright-Giemsa.
Pulse labeling of cells with [35S]methionine. Late erythroblasts isolated from liquid cultures were washed twice in MEM without methionine and resuspended in 10 mL of the same medium containing 10% FCS prewarmed to 37°C. The cells were then labeled with [35S]methionine (30 pCi/mL, 1000 Ci/mmol; ICN Biomedicals, Imine, CA) for different lengths of time. For the pulse-chase experiments, further incorporation of [35S]methionine was stopped by the addition of unlabeled methionine (0.4 mmol/L) and the incubation was then continued for different time periods. At the end of the labeling period, 10 vol of 155 mmol/L choline chloride and 5 mmol/L HEPES, pH 7.1, were added and the cells were harvested by centrifugation.
Cell fractionation and immunoprecipitation.
["SIMethioninelabeled cells were treated with diisopropyl fluorophosphate (Sigma Chemical Co, St Louis, MO), lysed in 4 vol of lysis buffer (150 mmol/L NaCl, 10 mmol/L TRIS-HCl, pH 7.2,5 mmol/L MgC12, 2 mmol/L EDTA, 0.25 mmol/L dithiothreitol, 1 mmol/L phenylmethyl sulphonyl fluoride, 1 mmol/L leupeptin, 10 pg/mL aprotinin, and 1 % Triton Xloo), and separated into soluble and insoluble fractions, as described earliep to measure rates of synthesis and assembly into the membrane skeleton, respectively. Spectrin was immunoprecipitated from these fractions using affinity-purified antispectrin antibodies by the method described previously?o For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
RNA isolation and qirantitation of a-spectrin and 8-spectrin
mRNAs by competitive PCR. Total cellular RNA was isolated from morphologically identical control and HPP erythroblasts by the guanidinium/cesium chloride method?' Total RNA was reverse transcribed into single-stranded cDNA using the antisense primers aSpB and j3SpB ( Fig I) . The reverse transcribed cDNA was co-amplified with a dilution series of either a 13-kb genomic a1 spectrin plasmid DNA2' using oligonucleotide primers aSpA and aSpB in exons 9 and IO of the a-spectrin gene23 or a 550-bp genomic j3-spectrin plasmid DNA using oligonucleotide primers j3SpA and j3SpB in exons X and Y ofthe 8-spectrin gene. 24 [32P] deoxycytidine triphosphate (dCTP) was included in the polymerase chain reaction (PCR) and 45 cycles ofamplification were performed with each cycle consisting of 1 minute at 94°C. 1 minute at 55"C, and 2 minutes at 72°C. After amplification, the samples were examined on an agarose gel containingethidium bromide, followed by autoradiography. The resulting autoradiograms were scanned and the area under each peak measured. The amount of gDNA was multiplied by the ratio ofcDNA bp per gDNA bp to correct for increased label incorporation per mole by the larger fragment. gDNA/cDNA was then plotted as a function ofthe amount of known competitive gDNA. The point where this ratio is I represents the concentration of cDNA in the ~nknown.~'
The j3-spectrin oligonucleotide primers (j3SpA and f i p B ) are approximately IO-fold less efficient than the a-spectrin primers as determined by PCR amplification of I pg each of genomic a-spectrin and 8-spectrin plasmid DNAs under identical conditions (data not shown). Accordingly, the j3-spectrin mRNA levels are multiplied by a factor of IO.
Sequencing and single-strand conformation polymorphism (SSCP) ana/.vsis of a-spectrin cDNA.
Total cellular RNA was reverse transcribed using random hexanucleotides (New England Biolabs, Beverly, MA) and PCR amplified with primers 404 (5'-TGAGGAAGAGGAAGCTTGGA-3'; bases 5667 to 5686) and 405 (5'-GGATGTCTTCTCCTTGTGCA-3'; bases 5839 to 5820) using the Perkin-Elmer (Norwalk, CT) GeneAmp PCR Reagents kit (45 cycles, 1 minute at 94"C, I minute at 52"C, 30 seconds at 72OC). An aliquot of the PCR product was cloned into plasmid pCR 1000 using theTA cloning kit (Invitrogen, San Diego, CA) and inserts were sequenced with the Sequenase version 2 sequencing kit (US Biochemical Corp, Cleveland, OH).
For single-strand conformation polymorphism (SSCP) analysis, reverse transcribed cDNA was PCR amplified in the presence of [32P]dCTP using a-spectrin primers404 and 405. The PCR product was heat denatured and separated by nondenaturing electrophoresis in Mutation Detection Enhancement (MDE) gel (AT Biochem, Inc, Malvem, PA), followed by autoradiography. greater than 90% of the cells are benzidine positive and a p pear to be at the late erythroblast (orthochromatophilic normoblast) stage as shown by Wright-Giemsa staining of the cytospin slides (Fig 2) . To ascertain that the two-phase liquid culture system used here to study spectrin synthesis reflects biosynthetic events as they occur in vivo, we have compared spectrin synthesis in the in vitro cultured erythroblasts with that in explanted human bone marrob (BM) erythroblasts and PB reticulocytes. The synthesis of a-spectrin and P-spectrin polypeptides was measured in an equal number of cells. The amounts of newly synthesized a-spectrin and P-spectrin polypeptides in the cultured erythroblasts and the a-spectrin to P-spectrin synthetic ratios were similar to those in the explanted BM erythroblasts and in reticulocytes when corrected for cell maturity based on the total cellular RNA content' (data not shown), which suggests that the in vitro culture conditions accurately reflect the synthetic events in explanted BM erythroblasts and thus are likely to be representative of biosynthetic events in in vivo.
RESULTS
In vitro cultured human erythroblasts replicate skeletal
A subset of patients with HPP carry a dekct involving reduced expression and synthesis of a-spectrin. As outlined above, in the most common type of HPP, the probands appear to inherit two defects: (1) an elliptocytogenic spectrin mutation inherited from one of the parents who is either asymptomatic or has a mild HE, and (2) another defect that augments the quantitative expression of the mutant spectrin in the cells producing a concomitant spectrin deficiency. Here we tested the hypothesis that this second defect represents a "thalassemia-like'' defect involving reduced spectrin synthesis. To address this possibility, we conducted pulse-labeling studies of an equal number of late erythroblasts isolated from cultures that were morphologically identical in terms of erythroblast stage. These studies showed that in the normal control and one parent who is an HE carrier, a-spectrin was synthesized in about threefold excess over 8-spectrin consistent with previous report^.^.^^,^^ In a striking contrast, in the asymptomatic carrier and the HPP proband, the synthesis of a-spectrin was markedly re- 1 07) of metabolically labeled cells. Amount of radioactivity in the aspectrin and j3-spectrin bands during the 90-minute labeling, obtained by densitometric scanning, is shown. The synthesis of aspectrin is markedly reduced in both the asymptomatic carrier and the proband. The difference in a-spectrin synthesis between C.B. and S.B. is simply a donor-to-donor variation. However, the assembly of a-spectrin and j3-spectrin polypeptides is normal in the asymptomatic carrier but is markedly reduced in the proband. In control, C.B., and S.B., the data are presented as mean values 2 SD observed in three separate experiments. In V.B., this experiment was done once because multiple blood samples were not available. duced, with an a-spectrin to p-spectrin synthetic ratio of 1.4 and 1.0, respectively ( Fig 3A) . Because the synthesis of pspectrin was within a normal range in all the subjects, these results clearly show that the synthesis of a-spectrin is markedly reduced in both the camer and the proband.
Next, we examined the assembly of newly synthesized spectrin polypeptides into the membrane skeleton. Measurements of the assembly of a-spectrin and b-spectrin polypeptides into the membrane skeletal fraction showed that in the asymptomatic carrier, the amounts of both a-spectrin and /3-spectrin polypeptides incorporated into the membrane skeleton were normal in spite of the above noted decrease in a-spectrin synthesis. In contrast, in the HPP proband, the assembly of a-spectrin and P-spectrin polypeptides in the membrane skeleton was reduced by 30% to 40% ( Fig 3B) . To further correct for the possible differences in the maturity of erythroblasts between control and patient, we also measured the assembly of newly synthesized ankyrin into the membrane skeleton, as described earlier.' Ankyrin was assembled in normal amounts in the proband as well as the two parents (data not shown).
Because the synthesis of a-spectrin is reduced in both the asymptomatic camer and the HPP proband, but the assembly of spectrin on the RBC membrane is reduced only in the proband, we examined the possibility that the mutant spectrin present in the proband was unstable. Indeed, pulsechase analysis showed that the turnover of the mutant spectrin present in the proband and the HE parent was faster than that of the normal spectrin: The half-life of newly synthesized a-spectrin (determined as the time required to reach the half-maximal radioactivity incorporation) in the HE parent and the HPP proband was 102 minutes and 110 minutes, respectively, compared with a half-life of 233 minutes in the asymptomatic camer (data not shown). Hence, we conclude that the reduced a-spectrin synthesis is asymptomatic in the parent who is hematologically normal, because the synthesis of a-spectrin, although diminished, remains in excess of p-spectrin. In contrast, in the HPP proband, reduced a-spectrin synthesis together with the instability of the mutant spectrin causes a partial spectrin deficiency.
To further elucidate the mechanism of reduced a-spectrin synthesis, we examined a-spectrin mRNA levels in the asymptomatic carrier and the HPP proband. Measurement of a-spectrin mRNA levels by competitive PCR technique showed that a-spectrin mRNA levels were markedly reduced in both the asymptomatic carrier and the HPP proband as compared with the normal control (Fig 4) . To assure that this difference was not caused by possible differences in cell age between cultured control and patient erythroblasts, we measured 0-spectrin mRNA levels in these individuals and the ratio of a-spectrin to P-spectrin mRNA levels was compared. As shown in Table 1 , the aspectrin to b-spectrin mRNA ratio was markedly reduced in both the asymptomatic carrier and the proband. The aspectrin and 0-spectrin mRNA levels in the HE parent were in the normal range (data not shown). These results are complementary to the synthetic studies described above suggesting that the synthesis of a-spectrin and b-spectrin polypeptides in erythroblasts is determined by their mRNA levels.
Although the molecular basis of reduced a-spectrin mRNA content is unknown, several possible defects at the DNA level could cause this phenotype (see Discussion section). Recently, a common, asymptomatic spectrin polymorphism has been found in association with a low expression of a-spe~trin.~'.** Therefore, we have asked whether or not this polymorphism is present in our subjects with HE and HPP. We have PCR amplified a cDNA fragment of 173 bp from the subjects S.B., C.B., and V.B. using primers specific for a-spectrin. The PCR products were sub- cloned, and multiple clones from each individual were pooled and sequenced. We found that both the proband (S.B) and the asymptomatic parent (C.B) were heterozygous for this polymorphism (AA 1857 leu-Val, CTA-GTA substitution), whereas the other parent (V.B) who cames the ellip tocytogenic mutation was normal (data not shown). These results show that in this particular situation the polymorphism is coinherited with the a-spectrin synthetic defect. However, further studies are required to determine whether or not this polymorphism is linked with the a-spectrin synthetic defect. mutation characterized by Arg-His (CGT-CAT) substitution at codon 28 of a-spectrin (data not shown), we have likewise postulated the presence of a second defect involving a reduced synthesis of a-spectrin. To test this, we conducted pulse-labeling studies similar to those described above for the first patient (S.B.). Indeed, we found similar results: The synthesis of a-spectrin was markedly reduced in both the asymptomatic camer and the HPP proband, whereas it was normal in the HE parent. Likewise, the assembly of the newly synthesized spectrin polypeptides into the membrane skeleton was normal in both parents but was reduced by about 40% in the HPP proband ( Fig 5) .
Next, we examined the a-spectrin mRNA levels in the HPP proband. In this case, because the HE mutation altered a restriction enzyme site (codon 28 Arg-His abolishes an AhaII sitez9) the mRNA transcriptsderived from each ofthe two spectrin alleles could be distinguished. Therefore, a 400-bp fragment of a-spectrin cDNA containing the muta-In the second HPP proband who cames the spectrin HPP proband (S.B.) erythroblasts. tion was PCR amplified followed by digestion with the enzyme AhaII. The digested PCR product was examined on an agarose gel, transferred to a zeta probe membrane, and hybridized with [32P]-labeled a-spectrin probe. As shown in Fig 6, the proband is heterozygous for the mutant allele that has lost the AhaII site and, hence, remains intact (400-bp 
fragment), whereas the normal allele is cleaved by Aha11
(260-bp and 140-bp fragments). Densitometric scanning of the resulting autoradiogram showed that the amount of the 260-bp fragment representing the structurally normal allele was at least fourfold to fivefold higher in the control as compared with the patient. These results clearly showed that in this HPP proband, the amount of the mRNA transcript derived from the structurally normal allele was markedly diminished. Similar measurements could not be done in the parents who were no longer available at the time these studies were executed. Additionally, to examine the presence of the spectrin polymorphism in this family, we used single-strand conformation polymorphism (SSCP) analysis that is capable ofdetecting single base changes in PCR products of 100 to 500 bp.30*3' As described above for the first patient (S.B.), a cDNA fragment of 173 bp was PCR amplified from subjects B.S. and P.S. (RNA from the other parent, K.S., was not available) using a-spectrin primers. The resulting PCR products were then subjected to SSCP analysis. We found that similar to the first family, the HPP proband (B.S.) was heterozygous for the av/4' polymorphism, whereas the parent (P.S.) carrying the elliptocytogenic mutation was normal (data not shown).
Increased turnover ora-spectrin before its assembly on the membrane leads to a partialspectrin deficiency in thesecond subset ofpatients with HPP. In contrast to the most characteristic pattern of HPP inheritance outlined in the preceding paragraph, some subjects with HPP are either homozygotes or double heterozygotes for two elliptocytogenic mutations. To elucidate the molecular basis of spectrin deficiency in this subset of patients, we studied synthesis of spectrin in morphologically identical erythroblasts of a control subject and a patient with HPP homozygous for spectrin mutation (leu-pro mutation at amino acid 207 of a-~pectrin.)'~ These studies showed that in this subject, both a-spectrin and j3-spectrin polypeptides were synthesized in normal amounts. However, the amount of both a-spectrin and (3-spectrin polypeptides assembled on the HPP erythroblast membrane was reduced to 40% to 50% of the normal values (Fig 7) consistent with reduced steady-state amounts of a-spectrin and 8-spectrin on the HPP erythrocyte mem-
branes."
Because the synthesis of both a-spectrin and j3-spectrin polypeptides was found normal, whereas their assembly on the membrane was markedly reduced, we explored the possibility that the reduced assembly of spectrin on the membrane was a consequence of accelerated degradation of the spectrin polypeptides before their assembly on the membrane. Indeed, pulse-chase analysis of the newly synthesized a-spectrin and j3-spectrin polypeptides showed a marked increase in the rate of turnover of a-spectrin in the HPP erythroblast cytosol as compared with a normal control.
The rate of turnover of j3-spectrin was also increased in HPP erythroblasts as compared with control erythroblasts. However, the latter could be caused by increased formation of /3-spectrin homodimers (in the absence of intact a-spectrin) that exhibit accelerated d e g r a d a t i~n .~~ In the proband's mother who is an asymptomatic spectrin a'/46 carrier, we also found an increase in the rates of turnover of a-spectrin and j3-spectrin polypeptides (data not shown). However, the synthesis and assembly of spectrin on the membrane was normal suggesting that the increased degradation ofthe mutant spectrin before its assembly on the membrane leads to spectrin deficiency in the homozygote offspring but is asymptomatic in a simple heterozygote.
DISCUSSION
In this report, we have defined two mechanisms underlying spectrin deficiency in a subset of patients with HPP. The first mechanism involves a compound heterozygote state for mutant a-spectrin or j3-spectrin and a defect representing reduced synthesis of a-spectrin. This is evidenced by pulse-labeling studies of in vitro cultured erythroblasts which showed that in contrast to controls, two unrelated HPP probands exhibited a marked decrease in the synthesis and mRNA levels of a-spectrin. Analysis of the parents of these subjects showed that although the synthesis of a-spectrin was normal in the parents carrying the elliptocytogenic spectrin mutation, the synthesis and mRNA levels of aspectrin were markedly decreased in the parents who are asymptomatic with no detectable abnormalities of spectrin structure and function. The inheritance of this synthetic defect in the asymptomatic carriers is unknown, because we were unable to study other members ofthese families. However, based on the fact that the decrease in the synthesis and mRNA level of a-spectrin is approximately 50%, it is likely to be inherited as a heterozygous defect. Moreover, if the camers were homozygous for this defect, the reduction in spectrin synthesis would be expected to be greater in the parents carrying two biosynthetically defective alleles than in the probands carrying one such allele, which is not the case.
The assembly of the newly synthesized a-spectrin and P-spectrin polypeptides into the membrane skeleton was normal in the asymptomatic parent but was reduced by 30% to 40% in the proband who contains a mutant spectrin. In the first patient, the mutant spectrin is truncated because of an in-frame deletion of exon 5 of a-spectrin." Pulse-chase analysis showed that in the HPP proband and the HE parent (both containing the mutant spectrin), newly synthesized spectrin underwent increased degradation before its assembly on the membrane suggesting a possibility that the mutant spectrin is unstable. Moreover, the fact that the steadystate levels of the truncated spectrin are relatively small (approximately 10% of total spectrin) in both the elliptocytic parent and the proband further supports the possibility that the mutant spectrin is unstable. Furthermore, because the truncated spectrin is the result of an in-frame deletion of exon 5,12 one could anticipate that this deletion will lead to an incorrect phasing of the repeat units, which in turn will cause an accelerated degradation of the mutant spectrin. This is consistent with recent findings3' that spectrin polypeptides with incorrectly phased repeating motifs yield unstable structures. Thus, our findings can be interpreted as follows: (1) In a simple heterozygous carrier, in whom one a-spectrin allele is normal, whereas the other allele exhibits reduced synthesis, the reduced a-spectrin synthesis is fully asymptomatic because the net synthesis of a-spectrin remains in excess of @-spectrin; and (2) in a double heterozygote who co-inherited a defect involving a reduced a-spectrin synthesis together with an unstable spectrin mutant, the amount of a-spectrin available for membrane assembly is markedly reduced causing a partial deficiency of spectrin.
Our findings of reduced a-spectrin synthesis in the asymptomatic carrier and the proband are further supported by our data indicating a marked decrease in their a-spectrin mRNA contents. The results presented in this article thus constitute a direct demonstration of an a-spectrin synthetic defect in an asymptomatic carrier of HPP. This synthetic defect, when transmitted to the HPP offspring, increases the quantitative expression of the a-spectrin mutant and causes a concomitant partial spectrin deficiency.
Recently, an asymptomatic spectrin polymorphism (aVl4') has been described" that is characterized by an increased susceptibility to proteolysis of the aIV-aV domain junction as a result of AA 1857 leu-Val substitution.'* In subjects with HE carrying mutant a-spectrin, the presence of this polymorphism in trans enhances the biochemical, morphologic, and clinical expression of the elliptocytogenic For personal use only. on November 11, 2017. by guest www.bloodjournal.org From spectrin Therefore, we have examined whether or not this polymorphism is present in our subjects with HE and HPP. We find that both the probands and the asymptomatic parent (of the first patient) carrying the defect of spectrin synthesis are heterozygous for this polymorphism (AA 1857 leu-val substitution), whereas the elliptocytogenic parents are normal. At this stage, the cause-effect relationship of this polymorphism and the a-spectrin synthetic defect is not known. However, homozygotes for the aVI4l defect are known to be asymptomatic and thus are unlikely to exhibit a markedly reduced synthesis of a-spectrin that would be expected to cause a severe spectrin deficiency. The molecular mechanism underlying reduced spectrin mRNA levels and synthesis in the patients reported above is unknown and is currently under study.
The second mechanism underlying spectrin deficiency in a subset of patients with HPP who are either homozygotes or doubly heterozygotes for one or two elliptocytogenic spectrin mutations appears to involve decreased stability of the mutant spectrin leading to reduced assembly of the mutant spectrin on the RBC membrane. This is suggested by the following findings: (1) in a subject with HPP who is a homozygote for a-spectrin a1/46 mutation, the synthesis of a-spectrin and /3-spectrin polypeptides was normal but their assembly on the erythroblast membrane was reduced to 40% to 50% of the normal values: and (2) pulse-chase analysis showed that in the HPP erythroblast cytosol, the rate of turnover of newly synthesized a-spectrin was markedly increased. The rate of turnover of /3-spectrin was also found to be increased in HPP erythroblasts. The latter result is in context with the previous studies in avian3' and mammalian (M. Hanspal et al, unpublished observation, 1990) erythroid cells that showed that the newly synthesized a-spectrin and 8-spectrin chains exist in the cytosol as heterodimers (the homooligomers undergo rapid degradation), and that the assembly of a-spectrin heterodimers is virtually instant.34 Hence, if a-spectrin is unstable within a given heterodimer, the corresponding /3-spectrin chain will also be expected to be unstable, because it cannot maintain its stability without the accompanying a-spectrin chain, and thus resulting in markedly reduced amounts of intact spectrin available for membrane assembly. In addition, it is possible that the markedly increased turnover of mutant spectrin in this patient is caused by an increased production of a protease. The results presented here suggest that the molecular basis of spectrin deficiency in this subject with HPP associated with a homozygous state for spectrin 0 1~'~ is at least in part the result of increased degradation of mutant spectrin before its assembly on the membrane.
In addition to the mechanisms discussed above, other possible abnormalities could account for partial spectrin deficiency in a subset of patients with HPP. One such possibility may be related to the stoichiometry of spectrin to ankyrin: In the normal RBC membrane, the spectrin-ankyrin binding stoichoimetry is one copy of ankyrin per spectrin tetramer.' Consequently, in patients with severely disrupted spectrin self-association and a marked increase in unassembled dimeric spectrin in the membrane, the number of an-kyrin binding sites may be insufficient to bind all spectrin dimers to the membrane.
Taken together, we show that the spectrin deficiency in HPP is a consequence of at least two molecular defects. The first defect involves reduced synthesis of a-spectrin that augments the quantitative expression of the mutant spectrin and causes a concomitant partial spectrin deficiency. The second defect involves increased degradation of mutant spectrin before its assembly on the membrane.
